Related references
Note: Only part of the references are listed.Ability of Noninvasive Scoring Systems to Identify Individuals in the Population at Risk for Severe Liver Disease
Hannes Hagstrom et al.
GASTROENTEROLOGY (2020)
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
Stephen A. Harrison et al.
JOURNAL OF HEPATOLOGY (2020)
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
Philip N. Newsome et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data
Rohit Loomba et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
COL6A3-derived endotrophin links reciprocal interactions among hepatic cells in the pathology of chronic liver disease
Changhu Lee et al.
JOURNAL OF PATHOLOGY (2019)
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2019)
Report on the AASLD/EASL joint workshop on clinical trial endpoints in NAFLD
Mary E. Rinella et al.
JOURNAL OF HEPATOLOGY (2019)
Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication
Jan-Bernd Funcke et al.
JOURNAL OF LIPID RESEARCH (2019)
Accuracy of Noninvasive Scoring Systems in Assessing Risk of Death and Liver-Related Endpoints in Patients With Nonalcoholic Fatty Liver Disease
Hannes Hagstrom et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Zobair M. Younossi et al.
LANCET (2019)
Human endotrophin as a driver of malignant tumor growth
Dawei Bu et al.
JCI INSIGHT (2019)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease
Hannes Hagstrom et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2017)
Liver Fibrosis Scores Predict Liver Disease Mortality in the United States Population
Aynur Unalp-Arida et al.
HEPATOLOGY (2017)
Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
Hannes Hagstrom et al.
JOURNAL OF HEPATOLOGY (2017)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo et al.
GASTROENTEROLOGY (2015)
Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up
Mattias Ekstedt et al.
HEPATOLOGY (2015)
Nonalcoholic Fatty Liver Disease A Systematic Review
Mary E. Rinella
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Utility and Appropriateness of the Fatty Liver Inhibition of Progression (FLIP) Algorithm and Steatosis, Activity, and Fibrosis (SAF) Score in the Evaluation of Biopsies of Nonalcoholic Fatty Liver Disease
Pierre Bedossa
HEPATOLOGY (2014)
Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction
Kai Sun et al.
NATURE COMMUNICATIONS (2014)
Endotrophin in the tumor stroma: a new therapeutic target for breast cancer?
Jiyoung Park et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2013)
Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo et al.
GASTROENTEROLOGY (2013)
Clinical, Laboratory and Histological Associations in Adults with Nonalcoholic Fatty Liver Disease
Brent A. Nettschwander-Tetri et al.
HEPATOLOGY (2010)
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
Richard K. Sterling et al.
HEPATOLOGY (2006)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Share Paper
